|
End-of-day quote
Dhaka S.E.
2026-09-03
|
5-day change | 1st Jan Change | ||
| 153.20 BDT | +3.51% |
|
+5.66% | +50.05% |
| 06-26 | Beximco suspension lifted; M1 payment date extension | AN |
| 06-24 | Beximco Pharmaceuticals PLC. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BEXIMCO PHARMACEUTICALS PLC. | Other Pharmaceuticals | +3.51% | +5.66% | +50.05% | +16.24% | -25.67% | 555M |
-
|
-
|
-
|
- Stock Market
- Stocks
- BXPHARMA Stock
- Charts Beximco Pharmaceuticals PLC.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
